Related Experiment Video
Updated: Mar 22, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
[Is Atrial Fibrillation a Pre-Thrombotic State?]
Insights
Atrial fibrillation (AF) creates a pre-thrombotic state, increasing stroke risk. Clinical prediction rules like CHA2DS2-VASc are crucial for identifying high-risk patients needing anticoagulation, balancing stroke prevention with bleeding risks.
Area of Science:
- Cardiology and Thrombosis
- Vascular Medicine
- Clinical Risk Prediction
Context:
- Atrial fibrillation (AF) is recognized as a pre-thrombotic state.
- Pathophysiology involves left atrial dilation, sluggish blood flow, and potential endothelial injury.
- Elevated markers like von Willebrand Factor (vWF) and D-dimer suggest hypercoagulability in AF patients.
Purpose:
- To review the challenges in identifying a high-risk pre-thrombotic state in non-valvular atrial fibrillation (NVAF).
- To highlight the clinical utility of stroke risk prediction scores in NVAF management.
- To emphasize the importance of balancing anticoagulation benefits against bleeding risks.
Summary:
- AF is a pre-thrombotic state due to factors like blood stasis and endothelial injury, though hypercoagulability is complex.
- The CHADS2 and CHA2DS2-VASc scores are established tools for estimating stroke risk in NVAF patients.
- These scores guide decisions on oral anticoagulant therapy, considering potential bleeding complications.
Impact:
- Clinical prediction rules are essential for guiding oral anticoagulant therapy decisions in NVAF.
- Accurate risk stratification helps personalize treatment, optimizing stroke prevention while minimizing bleeding risks.
- Further research may refine prediction models for better management of NVAF-related thrombotic events.
Abstract:
Atrial fibrillation (AF) is said to be a pre-thrombotic state. In patients with AF, the left atrium is usually dilated and blood flow is sluggish, which enables the formation of a thrombus within the left atrium. This is consistent with two of Virchow's Triad, stasis of blood flow and endothelial injury, but the last of the Triad, hypercoagulability of blood, is difficult to explain in AF. There are reports that von Willebrand Factor (vWF), FVIII, fibrinogen, D-dimer, and Fragment 1+2 are elevated in AF patients. The important thing in the daily clinical setting is to identify high-risk AF patients who are prone to stroke and treat them with oral anticoagulants. Over the last 15 years, two well known criteria to predict the risk have been proposed. The first one is called CHADS2 and the second one is the CHA2DS2-VASc score. The CHADS2 score is a clinical prediction rule for estimating the risk of stroke in patients with non-valvular atrial fibrillation (NVAF). A high CHADS2 score corresponds to a greater risk of stroke, while a low CHADS2 score corresponds to a lower risk. The CHA2DS2-VASc score was proposed to complement the CHADS2 score by the inclusion of additional risk factors. These prediction rules are important because not all NVAF patients require oral anticoagulant therapy. There are disadvantages to taking oral anticoagulants, primarily bleeding complications. Therefore, even prediction rules of bleeding risks have been proposed to screen NVAF patients. In conclusion, it is difficult to predict a high-risk pre-thrombotic state among NVAF patients based only on laboratory findings. Practically, prediction rules will play a major role in the decision to start oral anticoagulant therapy.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis I: Introduction
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Venous Thrombosis III: Interprofessional Care
Clot Retraction and Fibrinolysis
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...

